The B-specific consortium is proud to be mentioned in a recent paper in Nature Biotechnology entitled “The European Innovation Council supports innovative portfolios in health biotech”  LINK to paper and we would like to thank Iordanis Arzimanoglou for his work.

The European Innovation Council (EIC) was officially launched in March 2021 with the aim of creating an ecosystem that promotes deep-tech, science-based businesses by leveraging European research and development initiatives and unlocking Europe’s innovative potential. B-specific is participating in the EIC Cardiogenomics Challenge, which seeks to enhance the correlation between the well-established pathology of heart disease and various biomarkers.

The EIC Cardiogenomics portfolio is designed to offer valuable, interdisciplinary insights into how known and newly identified polymorphisms contribute to the susceptibility, onset, and progression of various forms of cardiovascular disease.

Here you can find the link: to open access version of the paper